Abstract

Simple SummaryThe actin-bundling protein Fascin is upregulated in many types of cancers, including adult T-cell leukemia/lymphoma, a tumor induced by the oncogenic retrovirus human T-cell leukemia virus type 1 (HTLV-1). Transcriptional regulation of Fascin is heterogeneous between different cell types and tissues, and Fascin is usually expressed at low levels in T-cells. We have previously shown that a single viral oncoprotein, Tax-1 of HTLV-1, is a potent inducer of Fascin in T-cells depending on classical NF-κB signaling. In this study, we discovered that transcriptional activation of Fascin by viral oncoproteins depends on activity of both the classical and the alternative NF-κB signaling cascade. Comparisons between Tax-1 and Tax-2 from the closely related but non-oncogenic HTLV-2 revealed that alternative NF-κB signaling discriminates transcriptional induction of Fascin by the Tax proteins encoded by HTLVs. Together, Tax-1 and Tax-2 proteins are useful tools to study oncogenic signaling in T-cells.Transcriptional regulation of the actin-bundling protein and tumor marker Fascin is highly diverse depending on cell and tumor type. Previously, we discovered that the viral oncoprotein Tax-1 of human T-cell leukemia virus type 1 (HTLV-1) considerably enhances Fascin expression in T-cells, depending on classical NF-κB signaling. In this study, we asked if the non-oncogenic Tax-2 of the related HTLV-2 is still able to induce Fascin by using luciferase assays, immunoblot, and qPCR. We found that Tax-2 only slightly induces Fascin expression compared to Tax-1; however, both Tax-1 and Tax-2 comparably activated a 1.6 kb fragment in the human Fascin promoter including Tax-responsive elements. Furthermore, we identified a link between Tax-induced activity of the alternative NF-κB pathway and Fascin induction. While treatment with the second mitochondria-derived activator of caspases (SMAC)-mimetic AZD5582, a compound known to robustly activate alternative NF-κB signaling, did not induce Fascin, combination of AZD5582 with activation of classical NF-κB signaling by Tax-2 significantly induced Fascin expression. In conclusion, our data demonstrate that both classical and alternative NF-κB activity are necessary for strong Fascin induction by the viral Tax oncoproteins, thus, shedding new light on the regulation of Fascin in T-cells and during viral transformation.

Highlights

  • Human T-cell leukemia virus type 1 (HTLV-1) was the first human oncogenic retrovirus to be discovered, which was isolated from a patient with cutaneous T-cell lymphoma [1]

  • Our data show that Tax-2 induces classical and alternative NF-κB signaling in Jurkat T-cells, leading to the hypothesis that alternative NF-κB activity is required for induction of Fascin expression

  • The actin-bundling protein Fascin is upregulated in many types of cancer, including virus-induced cancers such as adult T-cell leukemia/lymphoma (ATLL) [36], a neoplasia caused by the oncogenic retrovirus HTLV-1

Read more

Summary

Introduction

Human T-cell leukemia virus type 1 (HTLV-1) was the first human oncogenic retrovirus to be discovered, which was isolated from a patient with cutaneous T-cell lymphoma [1]. Ten percent of HTLV-1-infected patients acquire clinical symptoms manifesting in HTLV-1-related illnesses as adult T-cell leukemia/lymphoma (ATLL) after several decades of latency or HTLV-associated inflammatory conditions such as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) [1,5,6,7,8]. Multiple cases of neurodegenerative disorders of HTLV-2-infected patients and HAM/TSP-like symptoms have been described [15]. While HTLV-1 infects and transforms preferentially CD4+ T-cells in vivo, HTLV-2 is primarily detected in CD8+ T-cells [16,17]. Comparative studies between HTLV-1 and HTLV-2 have focused on uncovering the molecular mechanisms responsible for the differences in viral tropism, malignant transformation and clinical outcome in vivo [12]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call